TRUKEXUS
DEAD

Serial Number

88802065

Owner

Celgene Corporation

Attorney

Xiomara Triana

Filing Date

Feb 19, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TRUKEXUS Trademark

Serial Number: 88802065

TRUKEXUS is a trademark filed by Celgene Corporation on February 19, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

February 19, 2020

Registration Date

Not Registered

Published for Opposition

June 1, 2021

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, antifungal preparations, antivirals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer and cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy and T Cell therapy use; Pharmaceutical preparations for human use, namely, stem cells for medical and medical clinic purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 2, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 2, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 20, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jan 19, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 19, 2024 AITU
SOU EXTENSION 5 FILED
Jan 3, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 3, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2023 EXRA
SOU EXTENSION 4 GRANTED
Jul 13, 2023 EX4G
SOU EXTENSION 4 FILED
Jul 13, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jan 24, 2023 EX3G
SOU EXTENSION 3 FILED
Jan 24, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 24, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jul 13, 2022 EX2G
SOU EXTENSION 2 FILED
Jul 13, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 13, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 21, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 19, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 19, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 19, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 27, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 26, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 23, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 23, 2020 GNFN
FINAL REFUSAL E-MAILED
Oct 23, 2020 GNFR
FINAL REFUSAL WRITTEN
Oct 23, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 29, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2020 NWOS
NEW APPLICATION ENTERED
Feb 22, 2020 NWAP